Adam Kobayashi
Overview
Explore the profile of Adam Kobayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1850
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dyrbus K, Banach M, Gil R, Gasior M, Broncel M, Gellert R, et al.
Kardiol Pol
. 2025 Mar;
PMID: 40066957
Atherosclerosis is a systemic disease and involves not only the coronary vessels but also occurs in other vascular beds (e.g., cervical, cerebral, and peripheral vessels), increasing cardiovascular risk. One of...
2.
Pensato U, Tanaka K, Ospel J, Ospel J, Aviv R, Rodriguez D, et al.
Int J Stroke
. 2024 Dec;
17474930241307466.
PMID: 39623688
Background: Hematoma expansion (HE) occurs in one-fourth to one-third of patients with acute intracerebral hemorrhage (ICH) and is associated with worse outcomes. The co-localization of non-contrast computed tomography (NCCT) hypodensity...
3.
Tomasiewicz K, Woron J, Kobayashi A, Krasinski Z, Rydzewska G, Szymanski F
Pol Arch Intern Med
. 2024 Apr;
134(5).
PMID: 38619233
Post-COVID-19 syndrome, also known as long COVID-19 syndrome, is a complex set of symptoms that persist for weeks or months after recovery from an acute phase of COVID-19. These symptoms...
4.
Merks P, Chelstowska B, Religioni U, Neumann-Podczaska A, Krasinski Z, Kobayashi A, et al.
Med Sci Monit
. 2024 Mar;
30:e942923.
PMID: 38431771
New Medicine Service (NMS) components are an important element to improve patient compliance with medical recommendations. NMS provides support to patients prescribed new medicines, helping them to manage long-term conditions....
5.
Kazimierczyk E, Dabrowska M, Gierlotka M, Kapica-Topczewska K, Karaszewski B, Kobayashi A, et al.
Kardiol Pol
. 2024 Jan;
82(1):123-139.
PMID: 38230495
Andexanet alfa (AA) is a recombinant inactive analog of human activated factor X (FXa), effectively reversing the effects of its inhibitors - rivaroxaban and apixaban, which are available in Poland....
6.
Karlinski M, Kobayashi A, Niewada M, Fryze W, Tomczak A, Brola W, et al.
Neurol Neurochir Pol
. 2023 Dec;
58(1):75-83.
PMID: 38037889
Introduction: The Registry of Stroke Care Quality (RES-Q) is used in Poland for quality monitoring by numerous hospitals participating in the Angels Initiative. Our aim was to assess the degree...
7.
Psychogios M, Brehm A, Lopez-Cancio E, De Marchis G, Meseguer E, Katsanos A, et al.
Eur Stroke J
. 2022 Sep;
7(3):III-IV.
PMID: 36082254
The aim of the present European Stroke Organisation guideline is to provide clinically useful evidence-based recommendations on the management of patients with intracranial atherosclerotic disease (ICAD). The guidelines were prepared...
8.
Karlinski M, Kobayashi A, Karaszewski B, Czlonkowska A
Postepy Kardiol Interwencyjnej
. 2022 Aug;
18(1):1-3.
PMID: 35982739
No abstract available.
9.
Szymanski F, Mickiewicz A, Dzida G, Gorczyca-Glowacka I, Kozlowski D, Widecka K, et al.
Cardiol J
. 2021 Nov;
29(1):1-26.
PMID: 34811718
No abstract available.
10.
Ferro J, Bendszus M, Jansen O, Coutinho J, Dentali F, Kobayashi A, et al.
Int J Stroke
. 2021 Mar;
17(2):189-197.
PMID: 33724104
Background: The effect of different anticoagulants on recanalization after cerebral venous thrombosis has not been studied in a randomized controlled trial. Methods: RE-SPECT CVT (ClinicalTrials.gov number: NCT02913326) was a Phase...